Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Ultralife (ULBI) Shares Outstanding (2016 - 2025)

Ultralife has reported Shares Outstanding over the past 16 years, most recently at $21.1 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $21.1 million for Q4 2025, up 26.81% from a year ago — trailing twelve months through Dec 2025 was $21.1 million (up 26.81% YoY), and the annual figure for FY2025 was $21.1 million, up 26.81%.
  • Shares Outstanding for Q4 2025 was $16.7 million at Ultralife, roughly flat from $16.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding for ULBI hit a ceiling of $21.1 million in Q2 2025 and a floor of $16.6 million in Q3 2025.
  • Median Shares Outstanding over the past 5 years was $20.6 million (2021), compared with a mean of $20.3 million.
  • Biggest five-year swings in Shares Outstanding: dropped 19.97% in 2024 and later increased 26.81% in 2025.
  • Ultralife's Shares Outstanding stood at $20.6 million in 2021, then dropped by 0.01% to $20.6 million in 2022, then rose by 1.05% to $20.8 million in 2023, then fell by 19.97% to $16.6 million in 2024, then rose by 26.81% to $21.1 million in 2025.
  • The last three reported values for Shares Outstanding were $21.1 million (Q4 2025), $21.1 million (Q3 2025), and $21.1 million (Q2 2025) per Business Quant data.